OraSure Technologies, Inc. (OSUR) Fair Value 2026

OSUR · Medical Instruments & Supplies ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.8 /10

32 fundamental signals · 1 models active

Value Trap Risk

LOW (39/100)

Quick Summary — As of 2026-08-27, OraSure Technologies, Inc. (OSUR) trades at $3.69. QOC: 6.8/10. Value Trap Risk: 39/100 (LOW). 1/13 models active.

Key Facts

Ticker
OSUR
Price
$3.69
Quality Score
6.8/10
Value Trap Risk
39/100
Models Active
1/13
Last Updated
Strength: 1 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

What Fair Value Does Each Model Give OSUR?

1 Intrinsic Value Models vs. Current Price ($3.69)

Core Models (Unlocked)
Model Fair Value Upside
Asset-Based · High Conviction
 $3.62 -2.0%

All Models Active

All 1 models are displayed above.

What Is OraSure Technologies, Inc. (OSUR) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, OraSure Technologies, Inc. presents a highly debated valuation profile at its current price of $3.69. The median intrinsic value is estimated at $3.62 (-2.0% median upside), masking a wide model spread between the 0 bullish models and 0 bearish models.

What Do the Models Say About OSUR?

1 of 13 models are currently active for OSUR. All 1 active models suggest the stock trades above fair value. See which stocks rank higher →

How Does OSUR Rank in Medical Instruments & Supplies?

Among 55 Medical Instruments & Supplies stocks, OSUR ranks #26 by Quality of Company score. CirclFi's QOC score of 6.8/10 evaluates 32 fundamental signals. A score of 6.8 indicates above-average quality.

See all Most Undervalued Medical Instruments & Supplies Stocks →

OraSure Technologies, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is OSUR a Value Trap?

CirclFi's Value Trap algorithm assigns OSUR a score of 39/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for OraSure Technologies, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, OraSure Technologies, Inc. is rated at 6.8/10. This solid-tier score maintains reasonable quality metrics with some areas for improvement.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every OSUR valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across OSUR's 1 active models, average confidence is 52%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy OraSure Technologies, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Instruments & Supplies Stocks Should You Also Analyze?

11 related Medical Instruments & Supplies stocks with 13-model coverage

BLFSBioLife Solutions, Inc.QOC 6.9ANGOAngioDynamics, Inc.QOC 6.7NXGLNEXGEL, Inc.QOC 7.0AVTRAvantor, Inc.QOC 6.5SMTISanara MedTech Inc.QOC 7.1KRMDKORU Medical Systems, Inc.QOC 6.5KMTSKestra Medical Technologies, Ltd.QOC 5.8ZJYLJin Medical International Ltd.QOC 2.9UTMDUtah Medical Products, Inc.QOC 8.2ISRGIntuitive Surgical, Inc.QOC 9.4RMDResMed Inc.QOC 9.4

Read investment analysis: BLFS · ANGO · NXGL · AVTR · SMTI · KRMD · KMTS · ZJYL · UTMD · ISRG · RMD

Which Other Stocks Have a Similar Quality Score to OSUR?

7 companies across all industries closest to OSUR’s Quality of Company score of 6.8/10.

NREFNexPoint Real Estate Finance, Inc.QOC 6.8IFFInternational Flavors & Fragrances Inc.QOC 6.8CANGCango Inc.QOC 6.8INSGInseego Corp.QOC 6.8EMAEmera IncorporatedQOC 6.8LCTCLifeloc Technologies, Inc.QOC 6.8NVDANVIDIA CorporationQOC 10.0

Read investment analysis: NREF · IFF · CANG · INSG · EMA · LCTC · NVDA

Where Does OSUR Sit in CirclFi's Medical Instruments & Supplies Rankings?

OSUR is ranked against every other Medical Instruments & Supplies stock CirclFi covers in each of these screens.

See all Medical Instruments & Supplies stocks ranked →

What Else Do Investors Ask About OraSure Technologies, Inc.’s Valuation?

What is OraSure Technologies, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for OraSure Technologies, Inc. (OSUR). The Quality of Company score is 6.8/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is OSUR overvalued or undervalued right now?

At $3.69, 0 of 1 active models suggest OSUR may be undervalued, while 1 indicate potential overvaluation. The assessment depends on which methodology best fits OraSure Technologies, Inc.'s business model in Medical Instruments & Supplies.

What does a Quality of Company score of 6.8 mean for OSUR?

OraSure Technologies, Inc.'s QOC of 6.8/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on OSUR?

CirclFi analyzes OSUR with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is OSUR a value trap in 2026?

OraSure Technologies, Inc.'s Value Trap score is 39/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns OraSure Technologies, Inc. (OSUR) a Quality of Company score of 6.8/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/OSUR/ · Methodology
Primary sources for this OSUR valuation
  • Financial statements: OraSure Technologies, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001116463) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for OSUR as of ; valuations recomputed .